Biogen Alzheimer’s disease drug results impress, but more research still needed By: MarketWatch July 26, 2018 at 07:52 AM EDT Company shares have surged on investor hopes for the drug, but experts remain cautious. Read More >> Related Stocks: Biogen Idec Eisai Ltd ADR